Mio Kitano, M.D., M.S.

Dr. Kitano is an Associate Professor in the Division of Surgical Oncology & Endocrine Surgery at UT Health San Antonio. She completed her General Surgery Residency at Montefiore Medical Center/Albert Einstein College of Medicine. During her surgical training, she completed a 3-year clinical research fellowship at the National Institutes of Health. She now joins the Division of Surgical Oncology & Endocrine Surgery after completing a 2-year clinical fellowship in General Complex Surgical Oncology at the Ohio State University Wexner Medical Center. Dr. Kitano’s clinical practice focuses on the surgical management gastrointestinal tumors and malignancies, including those of the stomach, small bowel, colon, and pancreas.

• Professional Background

  Education

  • 2016 - MS - Master of Medical Science - The Ohio State University
  • 2016 - Clinical Fellowship - Complex General Surgical Oncology - The Ohio State University, Department of Surgery, Wexner Medical Center
  • 2014 - Residency - General Surgery - Albert Einstein College of Medicine
  • 2011 - Clinical Fellowship - Surgical Oncology - Surgery Branch, National Cancer Institute, NIH
  • 2009 - Clinical Fellowship - Immunotherapy - Surgery Branch, National Cancer Institute, NIH
  • 2008 - Residency - General Surgery - State University of New York, Upstate Medical University
  • 2007 - Residency - General Surgery - State University of New York, Upstate Medical University
  • 2006 - MD - Medicine (Cum Laude) - St. George`s University School of Medicine
  • 2002 - BS - Biology; Minor in Biochemistry and Psychology (Magna Cum Laude,Mendelian Medal of Honor) - Manhattan College

  Appointments

  • 9/2016 - Assistant Professor/Clinical - UT Health San Antonio, Surgery, San Antonio
  • 9/2016 - Staff physician - University Health SystemSan Antonio

• Instruction & Training

  • 10/2019 - Present, Individual Instruction, UT Health San Antonio
  • 9/2019 - Present, Shirley Nah: Surgical Oncology Research Group, UT Health San Antonio
  • 9/2019 - Present, Undergraduate Student Supervision, UT Health San Antonio
  • 1/2019 - Present, Individual Instruction, UT Health San Antonio
  • 1/2018 - Present, Individual Instruction, UT Health San Antonio
  • 1/2018 - Present, Individual Instruction, UT Health San Antonio
  • 1/2018 - Present, Individual Instruction, UT Health San Antonio
  • 1/2018 - Present, Individual Instruction, UT Health San Antonio
  • 9/2016 - Present, Cancer Biology Enrichment Lecture Series, UT Health San Antonio
  • 9/2016 - Present, Surgical Oncology Grand Rounds, UT Health San Antonio
  • 9/2016 - Present, General Surgery PGY-1, PGY-2, and PGY-5 teaching, UT Health San Antonio
  • 9/2016 - Present, Surgery Clerkship, The University of Texas Health Science Center
  • 9/2016 - Present, Surgical Oncology, The University of Texas Health Science Center

• Publications

  Book Chapter

  1.Kitano M, Patterson E, Kebebew E. Adrenocortical Tumors In: Kitano M, Patterson E, Kebebew E. Cancer: Principles and Practice of Oncology, 9th Edition. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2011.

  2.Kitano M. Whipple and Distal Pancreatectomy (under review) In: Surgeries Made Easy: Quick Guide for Residents and Medical Students. Cambridge Scholar Publishing Group;

  Journal Article

  1.Lyell N, Smith B, Jones EL, Kitano M, Gleisner AL, Cheng G, McCarter MD, Backes FJ, Abdel-Misih. The Effect of Preoperative Nutritional Status on Postoperative Complications and Overall Survival in Patients Undergoing Pelvic Exenteration: A Multi-Disciplinary, Multi-institutional Cohort Study. pii: S0002-9610(18)31612. PMID: 30982571 Am J Surg 2019 Apr;9610(18)

  2.Smith B, Jones EL, Kitano M, Gleisner AL, Lyell NJ, Cheng G, McCarter MD, Abdel-Misih S, Backes FJ. Influence of tumor size on outcomes following pelvic exenteration. 2017 Nov;147(2):345-350. doi: 10.1016/j.ygyno.2017.08.014. Epub 2017 Aug 16 Journal of Gynecologic Oncology 2017 Nov;147(2):345-350.

  3.Kitano M, Davidson GW, Shirley LA, Schmidt CR, Guy GE, Khabiri H, Dowell JD, Shah MH, Bloomston M. Transarterial Chemoembolization for Metastic Neuroendocrine Tumors with Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk? 2016 Nov;23(12):4008-4015. Epub 2016 Jul 8. Ann Surg Oncol 2016 Jul;23(12):4008-4015.

  4.Kitano M,Bloomston M. Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. 2016 Mar 16;5(3). pii: E38. doi: 10.3390/jcm5030038 Journal of Clinical Medicine 2016 Mar;5(3):E38-E38.

  5.Kitano M, Maker AV, Lanier BJ, Danforth DN, Kammula U. Appendicitis Secondary to Metastatic Melanoma: Review of the National Institutes of Health Experience. 2014 Jul;149(7):735-8. doi: 10.1001/jamasurg.2013.4067. PMID: 24871401 JAMA Surg 2014 May;149(7):735-738.

  6.Weisbrod AB, Kitano M, Williams D, Gulati N, Gesuwan K, Liu Y, Venzon D, urkbey I, Choyke P, Yao J, Libutti SK, Nilubol N, Linehan WM, Kebewew E.. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. 2014 Feb;218(2):163-9. doi: 10.1016/j.jamcollsurg.2013.10.025. Epub 2013 Nov 12 J Am Coll Surg 2014 Feb;218(2):163-169.

  7.Rahbari R, Kitano M, Zhang L, Bommareddi S, Patterson EE, Jain M, Kebebew E.. RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function. 2013 Mar;98(3):E446-54. doi: 10.1210/jc.2012-3180. Epub 2013 Feb 7. PMID: 23393170 J Clin Endocrinol Metab 2013 Mar;98(3)

  8.Weisbrod A, Kitano M, Gesuwan K, Millo C, Herscovitch P, Nilubol N, Linehan WM, Kebebew E. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. 2012 Apr;97(4):E613-7. doi: 10.1210/jc.2011-2626. Epub 2012 Jan 18. PMID: 22259055 The Journal of Clinical Endocrinology and Metabolism 2012 Apr;97(4):E613-E617.

  9.Kitano M, Rahbari R, Patterson E, Steinberg S, Prasad N, Wang Y, Zeiger M, Kebebew E. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. 2012 Mar;22(3):285-91. doi: 10.1089/thy.2011.0313. Epub 2012 Feb 3 Thyroid 2012 Mar;22(3):285-291.

  10.Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E.. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. doi: 10.1016/j.surg.2011.09.048 PMID: 22136831 Surgery 2011 Dec;150(6):1122-1128.

  11.Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Debebew E.. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs. doi: 10.1245/s10434-011-1766-4. Epub 2011 May 7. PMID: 21553140 Annals of Surgical Oncology 2011 Nov;18(12):3443-3452.

  12.Mathur A, Weng J, Moses W, Steinberg SM, Rahbari R, Kitano M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E.. A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery. doi: 10.1016/j.surg.2010.09.025. PMID: 21134548 Surgery 2010 Dec;148(6):1170-1177.

  13.Rahbari R, Mathur A, Kitano M, Guerrero M, Shen WT, Duh QY, Clark OH, Kebebew E. Prospective Randomized Trial of Ligasure Versus Harmonic Hemostasis Technique in Thyroidectomy Annals of Surgical Oncology 2010 Nov

  14.Kemp CD, Kitano M, Kerkar S, Ripley RT, Marquardt JU, Schrump DS. Pulmonary resection for metastatic gastric cancer. doi: 10.1097/JTO.0b013e3181ed3514. PMID: 20881648 J Thorac Oncol 2010 Nov;5(11):1796-1805.

  15.Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther. 2010 Apr;18(4):843-51. doi: 10.1038/mt.2010.24. Epub 2010 Feb 23. PMID: 20179677 Mol Ther 2010 Apr;18(4):843-851.

   

• Clinical

  Board Certifications

  • 2017 - Complex General Surgical Oncology-Diplomate, American Board of Surgery
  • 2015 - General Surgery-Diplomate, American Board of Surgery